CSF2RB and metastatic melanoma: Four groups of ceRNA interacting triplets were obtained (RP11-594N15.3–miR3662-CSF2RB, RP11-594N15.3–miR3662-ZNF831, RP11-594N15.3–miR3662-PKIA, AC104024.1–miR346-PKIA), of which miR3662 may have potential for the treatment of metastatic melanoma (Fig. 4J).